Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mo'tasem M Alsmadi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2026
P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modelingMo'tasem M Alsmadi
European Journal of Drug Metabolism and Pharmacokinetics|August 10, 2023
Evaluating the Pharmacokinetics of Fentanyl in the Brain Extracellular Fluid, Saliva, Urine, and Plasma of Newborns from Transplacental Exposure from Parturient Mothers Dosed with Epidural Fentanyl Utilizing PBPK ModelingMo'tasem M Alsmadi
Drug Metabolism and Personalized Therapy|October 7, 2022
The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modelingMo'tasem M Alsmadi
Drug Metabolism and Personalized Therapy|August 8, 2024
Bottom-up PBPK modeling of phenytoin brain disposition in postpartum newborns after intrauterine dosingMo'tasem M Alsmadi
Therapeutic Drug Monitoring|February 17, 2024
Salivary Therapeutic Monitoring of Buprenorphine in Neonates After Maternal Sublingual Dosing Guided by Physiologically Based Pharmacokinetic ModelingMo'tasem M Alsmadi
The International Journal of Pharmacy Practice|February 18, 2017
Pharmacy education in Jordan: updatesQais Alefan, Mo'tasem M Alsmadi
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2023
The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK ModelingMo'tasem M Alsmadi, Nasir Idkaidek
Current Drug Metabolism|July 3, 2018
Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An UpdateMo'tasem M Alsmadi, Nasir Idkaidek
AAPS Pharmscitech|July 2, 2026
The Preparation and Physicochemical Characterization of a Triple Synergistic Nanoplatform Designed for Targeted Subcutaneous Delivery of Sitagliptin with Potential for β-Cell PreservationMo'tasem M Alsmadi, Rana Obaidat
Biopharmaceutics & Drug Disposition|November 1, 2022
In vitro-in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to humanMo'tasem M Alsmadi, Saja B Alzughoul
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2026
P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modelingMo'tasem M Alsmadi
European Journal of Drug Metabolism and Pharmacokinetics|August 10, 2023
Evaluating the Pharmacokinetics of Fentanyl in the Brain Extracellular Fluid, Saliva, Urine, and Plasma of Newborns from Transplacental Exposure from Parturient Mothers Dosed with Epidural Fentanyl Utilizing PBPK ModelingMo'tasem M Alsmadi
Drug Metabolism and Personalized Therapy|October 7, 2022
The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modelingMo'tasem M Alsmadi
Drug Metabolism and Personalized Therapy|August 8, 2024
Bottom-up PBPK modeling of phenytoin brain disposition in postpartum newborns after intrauterine dosingMo'tasem M Alsmadi
Therapeutic Drug Monitoring|February 17, 2024
Salivary Therapeutic Monitoring of Buprenorphine in Neonates After Maternal Sublingual Dosing Guided by Physiologically Based Pharmacokinetic ModelingMo'tasem M Alsmadi
The International Journal of Pharmacy Practice|February 18, 2017
Pharmacy education in Jordan: updatesQais Alefan, Mo'tasem M Alsmadi
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2023
The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK ModelingMo'tasem M Alsmadi, Nasir Idkaidek
Current Drug Metabolism|July 3, 2018
Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An UpdateMo'tasem M Alsmadi, Nasir Idkaidek
AAPS Pharmscitech|July 2, 2026
The Preparation and Physicochemical Characterization of a Triple Synergistic Nanoplatform Designed for Targeted Subcutaneous Delivery of Sitagliptin with Potential for β-Cell PreservationMo'tasem M Alsmadi, Rana Obaidat
Biopharmaceutics & Drug Disposition|November 1, 2022
In vitro-in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to humanMo'tasem M Alsmadi, Saja B Alzughoul
Pageof 3